Teva Expects $$16 Billion in Revenue
Teva Pharmaceutical predicts 15% revenue growth to $16 billion in the coming year. In the fourth quarter of 2009, Teva offered $747 million in its well drug for multiple sclerosis, Copaxone. Worldwide Copaxone sales came to $2.82 billion in 2009, 25% more than in 2008. Teva stated that it is waiting for US Food and Drug Administration approval for 216 generic drugs.
News Briefs
More News Briefs
Israel Hotels Powerful Purim Video Easy Purim Gifts Made in Israel Yeshivas Gili's Goodies - The Video
© , | Home Page | Contact | Advertise | Israel Tours |
Sites of Interest: Judaica Mall - Jewish Gifts Purim Gifts Gili's Goodies - The Video Powerful Purim Video
Check out - humorous, Entertaining Videos --
News Briefs
More News Briefs
Israel Hotels Powerful Purim Video Easy Purim Gifts Made in Israel Yeshivas Gili's Goodies - The Video
© , | Home Page | Contact | Advertise | Israel Tours |
Sites of Interest: Judaica Mall - Jewish Gifts Purim Gifts Gili's Goodies - The Video Powerful Purim Video
